Objective: This study aims to investigate the correlation between changes in bone mineral density (BMD) in postmenopausal women and circulating inflammatory markers.Methods: This retrospective study focused on postmenopausal women admitted to the orthopedic department of Suzhou Benq Medical Center from June 2022 to December 2023, following predetermined inclusion and exclusion criteria. We retrospectively collected data on initial blood routine test results and bone density measurements for all study subjects upon admission, including parameters such as white blood cell count (WBC), C‐reactive protein, interleukin‐6 (IL‐6), and procalcitonin (PCT). Additionally, the systemic immune‐inflammation index (SII) was calculated using neutrophil count, lymphocyte count, and platelet count. Statistical analyses using SPSS and GraphPad software were performed to assess the correlation between bone density and inflammatory markers.Results: Patients were classified into three groups based on BMD results, including 60 individuals in the osteoporosis (OP) group, 127 individuals in the osteopenia group, and 37 individuals in the Normal group, respectively. Principal component analysis analysis suggested that WBC, SII, and postmenopausal OP (PMOP) held significant feature values. Correlation analysis indicated a correlation between WBC (p = 0.021), IL‐6 (p = 0.044), SII (p = 0.034), and PMOP. One‐way ANOVA analysis revealed significant differences in IL‐6 (p = 0.0179), SII (p = 0.0210), and PCT (p = 0.0200) among the three groups. Finally, ROC curve analysis demonstrated that SII (area under the curve = 0.716) has predictive value for PMOP.Conclusion: This study identified a certain predictive value for PMOP through the assessment of inflammatory markers in peripheral blood using routine blood tests.
Copper is a vital trace element integral to numerous biological processes, including iron metabolism, neurotransmitter synthesis, mitochondrial respiration, oxidative stress regulation, and energy production. However, disturbances in copper metabolism can result in pathological conditions, including cuproptosis—a newly recognized form of programmed cell death (PCD) marked by copper accumulation and the disruption of copper-dependent metabolic pathways. Cuproptosis has been associated with various diseases, such as cancer, metabolic disorders and neurodegenerative disorders. In the context of spinal cord injury (SCI), multiple pathological mechanisms, including oxidative stress, inflammation, and PCD could impact the patient’s prognosis with SCI. This review seeks to elucidate the pathophysiological underpinnings of SCI, the mechanisms and biological significance of copper homeostasis and the role of cuproptosis in SCI.
The Rab7 belongs to the Ras small GTPase superfamily, and the abnormal expression of Rab7 can cause neuropathy and lipid metabolism disease. However, the regulatory mechanism was not explicitly clear. Studies show that its plays crucial role inner membrane translocase. However, the role of Rab7 on the regulatory mechanisms of cell survival is still unknown. We performed a rat spinal cord injury (SCI) model to explore the cellular localization and expression of Rab7 after SCI in this study. Western blot has found that Rab7 was expressed in the spinal cord tissue. On the first day, it significantly increased, then decreased at 48 h, and on the third day reached a peak after SCI. what important is that Rab7 was colocalized with neurons. Furthermore, Western blot was also demonstrated that the pyroptosis-related protein (GSDMD , Caspase-1, ASC) expression attained the peak after the third-day post-injury. Importantly, the immunohistochemistry analysis revealed that Rab7 was completely colocalized with ASC in the neuron after SCI. These results suggested that Rab7 was colocalized with the neurons and involved in the pyroptosis of neurons and closely related to the spinal cord after injury.
31 January 2026 in Journal of International Medical Research
Objectives: This study aimed to comprehensively investigate the possible associations between neutrophil- and high-density lipoprotein cholesterol (HDL-C)–related inflammatory markers and the incidence of sarcopenia among adults in the United States. Methods: This cross-sectional study analyzed data from 8878 participants in the National Health and Nutrition Examination Survey. The potential associations between neutrophil- and HDL-C–related inflammatory markers and sarcopenia were evaluated using multiple statistical methods, including weighted logistic regression analysis, sensitivity analyses, restricted cubic spline models, and subgroup analyses. A receiver operating characteristic curve was employed to thoroughly analyze the predictive accuracy of various inflammatory markers for sarcopenia risk. Results: All examined inflammatory markers were significantly associated with sarcopenia. The association between the neutrophil-to-HDL-C ratio and sarcopenia was nonlinear, with risk increasing notably beyond a certain threshold (breakpoint = 2.791), whereas the neutrophil percentage-to-albumin ratio demonstrated a linear association. Further threshold effect analyses identified specific breakpoints for neutrophil-to-HDL-C ratio, platelet-to-HDL-C ratio, lymphocyte-to-HDL-C ratio, and monocyte-to-HDL-C ratio. Notably, the area under the curve value for neutrophil-to-HDL-C ratio exceeded those for other inflammatory markers in receiver operating characteristic analysis (area under the curve = 0.632, 95% confidence interval: 0.612–0.652), suggesting its potential as a promising predictor of sarcopenia prevalence. Conclusions: The findings suggest positive associations between inflammatory biomarkers and sarcopenia, with the neutrophil-to-HDL-C ratio demonstrating superior predictive performance.
Objective: This study aims to investigate the correlation between changes in Bone Mineral Density (BMD) in postmenopausal women and circulating inflammatory markers. Methods: This retrospective study focused on postmenopausal women admitted to the orthopedic department of Suzhou Benq Medical Center from June 2022 to December 2023, following predetermined inclusion and exclusion criteria. We retrospectively collected data on initial blood routine test results and bone density measurements for all study subjects upon admission, including parameters such as White Blood Cell count (WBC), C-reactive protein (CRP), Interleukin-6 (IL-6), and Procalcitonin (PCT). Additionally, the Systemic Immune-inflammation Index (SII) was calculated using Neutrophil Count, Lymphocyte Count, and Platelet Count. Statistical analyses using SPSS and GraphPad software were performed to assess the correlation between bone density and inflammatory markers. Results: Patients were classified into three groups based on BMD results, including 60 individuals in the Osteoporosis (OP) group, 127 individuals in the Osteopenia (ON) group, and 37 individuals in the Normal (NO) group, respectively. Principal Component Analysis (PCA) analysis suggested that WBC, SII, and PMOP held significant feature values. Correlation analysis indicated a correlation between WBC (P=0.021), IL-6 (P=0.044), SII (P=0.034), and PMOP. One-way ANOVA analysis revealed significant differences in IL-6 (P=0.0179), SII (P=0.0210), and PCT (P=0.0200) among the three groups. Finally, ROC curve analysis demonstrated that SII (area under the curve = 0.716) has predictive value for PMOP. Conclusion: This study identified a certain predictive value for PMOP through the assessment of inflammatory markers in peripheral blood using routine blood tests.